Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

237 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Among authors: hyrich kl. Arthritis Rheum. 2006 Aug;54(8):2368-76. doi: 10.1002/art.21978. Arthritis Rheum. 2006. PMID: 16868999
Infectious agents in chronic rheumatic diseases.
Hyrich KL, Inman RD. Hyrich KL, et al. Curr Opin Rheumatol. 2001 Jul;13(4):300-4. doi: 10.1097/00002281-200107000-00010. Curr Opin Rheumatol. 2001. PMID: 11555732 Review.
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL, Symmons DP, Watson KD, Silman AJ; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Arthritis Rheum. 2006 Jun;54(6):1786-94. doi: 10.1002/art.21830. Arthritis Rheum. 2006. PMID: 16736520
237 results